Business
datma and Rhythm Biosciences Announce Collaboration to Apply Federated Real-World Data to Genomic Diagnostic Development
datma, a leader in federated real-world data access, and Rhythm Biosciences Ltd (ASX:RHY), a leading developer in predictive cancer diagnostics technology including its geneType™ risk assessment portfolio, today announced an exploratory collaboration to evaluate how datma.FED, datma's federated data platform, could support and accelerate the commercialization of Rhythm's genomic-integrated cancer risk prediction portfolio.
About this update from Rhythm Biosciences Limited
[{"type":"text","content":"The two companies will explore how datma's federated ecosystem can support Rhythm Biosciences' diagnostic development efforts as they shape a future commercial agreement.","length":178,"tagName":"p"},{"type":"text","content":"BEAVERTON, Ore. and PARKVILLE, Australia, Dec. 22, 2025 /PRNewswire/ -- datma, a leader in federated real-world data access, and Rhythm Biosciences Ltd (ASX:RHY), a leading developer in predictive cancer diagnostics technology including its geneType™ risk assessment portfolio, today announced an exploratory collaboration to evaluate how datma.FED, datma's federated data platform, could support and accelerate the commercialization of Rhythm's genomic-integrated cancer risk prediction portfolio.","length":511,"tagName":"p"},{"type":"image","alt":"datma.com","displaySize":"","headline":null,"caption":"datma.com","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":123,"url":"https://media.zenfs.com/en/prnewswire.com/6ea668e578b8f154a1a9e4668faafab5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_mJcd7.C7FXR9dzIFzWreQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIxNztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/6ea668e578b8f154a1a9e4668faafab5","width":400,"height":123}},"href":"https://mma.prnewswire.com/media/2849969/datma_Inc_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"As genomic-integrated stratification tools evolve, access to high-quality real-world data is becoming more important for supporting development, improving model performance, and broadening clinical relevance. However, the data sets needed to advance these capabilities are often difficult to access due to fragmentation and privacy constraints. datma.FED addresses these challenges by enabling secure, federated access to de-identified data across participating healthcare organizations without requiring data to be centralized or moved.","length":537,"tagName":"p"},{"type":"text","content":"Through this collaboration, datma and Rhythm Biosciences will assess how longitudinal, de-identified real-world clinical data accessible via datma.FED may contribute to the continued development of Rhythm's genomic-integrated risk scoring technologies. Rhythm intends to explore the use of these datasets to support clinical utility evidence generation and health economic m...